Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Home
ETF
AORT
AORT
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
AORT News
Artivion to Participate in Oppenheimer Healthcare Conference
6d ago
PRnewswire
Artivion, Inc. Reports Strong Q4 2025 Earnings Growth
Feb 13 2026
seekingalpha
Artivion (AORT) Q4 2025 Earnings Call Transcript
Feb 13 2026
NASDAQ.COM
Artivion Reports Strong 2025 Earnings, Outlook for Growth in 2026
Feb 13 2026
Yahoo Finance
HOLX's Innovative AI Mammography Identifies Overlooked Breast Cancer Cases
Dec 17 2025
NASDAQ.COM
Artivion Insider Offloads Shares Valued at $576,502, Per Recent SEC Disclosure
Nov 18 2025
Yahoo Finance
Artivion Insider Offloads Shares Valued at $264,188, Based on Recent SEC Disclosure
Nov 14 2025
Yahoo Finance
Artivion (AORT): Is the Healthcare Leader Appropriately Priced Following Recent Gains?
Nov 09 2025
Yahoo Finance
Canaccord Genuity Keeps Buy Rating on Artivion and Increases Price Target to $51
Nov 07 2025
Benzinga
Artivion Stock: An In-Depth Look at Analyst Opinions (6 Ratings)
Nov 07 2025
Benzinga
Needham Keeps Buy Rating on Artivion and Increases Price Target to $58
Nov 07 2025
Benzinga
Artivion Reports Third Quarter 2025 Financial Results
Nov 06 2025
PRnewswire
Artivion Announces Treatment of First Patient with Arcevo LSA in ARTIZEN Pivotal Trial
Nov 06 2025
PRnewswire
AORT Surpasses Average Analyst Price Target
Oct 31 2025
NASDAQ.COM
Artivion Announces Release Date and Teleconference Call Details for Third Quarter 2025 Financial Results
Oct 23 2025
PRnewswire
Artivion Announces Presentation of Late-Breaking Data from AMDS PERSEVERE and AMDS PROTECT Trials at the 39th European Association for Cardio-Thoracic Surgery (EACTS) Annual Meeting
Oct 13 2025
PRnewswire
Show More News
